Name | Type | Posted | Actions |
|---|---|---|---|
RFP_Number_75N95023R00029_and_Attachments.pdf | May 26, 2023 |
Safety Evaluation and Toxicology Studies and Related Services for Drug Development
Contact and place of performance
—
Not specified
No narrative description provided for this notice.
The National Institutes of Health, specifically the National Institute on Drug Abuse (NIDA), issued solicitation number 75N95023R00029 for safety evaluation, toxicology studies, and related services to support drug development. This requirement is categorized under NAICS code 541715, which corresponds to Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology), and PSC code AN11, which covers Health Research and Development Services; Biomedical; Basic Research.
The procurement documentation was updated on June 26, 2023, following the initial publication of the request for proposals. The formal solicitation package, identified as RFP_Number_75N95023R00029_and_Attachments.pdf, was posted on May 26, 2023. This document contains the comprehensive requirements and instructions for providing the necessary toxicological and safety assessments required for the development of drug candidates.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.